CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-12-03 | Farricielli Joseph J. Jr. Director | Purchase | +10,000 | $0.13 | $1K | 56,000 |
| 2008-12-02 | Farricielli Joseph J. Jr. Director | Purchase | +300 | $0.14 | $42 | 46,000 |
| 2008-12-01 | Farricielli Joseph J. Jr. Director | Purchase | +8,700 | $0.14 | $1K | 45,700 |
| 2008-11-28 | Farricielli Joseph J. Jr. Director | Purchase | +1,000 | $0.14 | $140 | 37,000 |
| 2008-11-12 | Farricielli Joseph J. Jr. Director | Purchase | +5,000 | $0.13 | $650 | 36,000 |
| 2008-11-11 | Farricielli Joseph J. Jr. Director | Purchase | +15,000 | $0.14 | $2K | 31,000 |
| 2008-11-06 | Keymer Kenneth L Director | Grant or award · Director Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2008-11-01 | Bateman Terry Allan Director | Grant or award · Director Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2008-10-31 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +100,000 | $0.13 | $13K | 7,062,927 |
| 2008-10-29 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +200,600 | $0.13 | $26K | 6,962,927 |
| 2008-09-30 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +21,200 | $0.22 | $5K | 6,762,327 |
| 2008-09-24 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +69,500 | $0.22 | $15K | 6,741,127 |
| 2008-09-23 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +100,000 | $0.22 | $22K | 6,671,627 |
| 2008-09-22 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +100,000 | $0.22 | $22K | 6,571,627 |
| 2008-09-19 | Berg Jeffrey Alan Director | Purchase | +1,500,000 | $0.25 | $375K | 4,168,057 |
| 2008-09-19 | Berg Jeffrey Alan Director | Purchase | +27,543 | $0.22 | $6K | 4,195,600 |
| 2008-09-19 | Berg Jeffrey Alan Director | Purchase | +1,500,000 | $0.25 | $375K | 4,192,057 |
| 2008-09-19 | Berg Jeffrey Alan Director | Purchase | +27,543 | $0.22 | $6K | 4,219,600 |
| 2008-09-18 | Berg Jeffrey Alan Director | Purchase | +16,602 | $0.22 | $4K | 2,668,057 |
| 2008-09-18 | Berg Jeffrey Alan Director | Purchase | +16,602 | $0.22 | $4K | 2,692,057 |
Page 32 of 33 · 657 trades